METHYLDOPA - search results

United States - English - NLM (National Library of Medicine)

methyldopa tablet film coated

teva pharmaceuticals usa inc - methyldopa (unii: 56lh93261y) (methyldopa anhydrous - unii:m4r0h12f6m) - methyldopa anhydrous 250 mg

United States - English - NLM (National Library of Medicine)

methyldopa tablet film coated

avera mckennan hospital - methyldopa (unii: 56lh93261y) (methyldopa anhydrous - unii:m4r0h12f6m) - methyldopa anhydrous 500 mg

United States - English - NLM (National Library of Medicine)

methyldopa tablet, film coated

chartwell rx, llc - methyldopa (unii: 56lh93261y) (methyldopa anhydrous - unii:m4r0h12f6m) - methyldopa is contraindicated in patients: — with active hepatic disease, such as acute hepatitis and active cirrhosis — with liver disorders previously associated with methyldopa therapy ( see warnings ) — with hypersensitivity to any component of these products. — on therapy with monoamine oxidase (mao) inhibitors.

New Zealand - English - Medsafe (Medicines Safety Authority)

methyldopa viatris

viatris limited - methyldopa sesquihydrate 283mg equivalent to to 250 mg methyldopa anhydrous; - tablet - 250 mg - active: methyldopa sesquihydrate 283mg equivalent to to 250 mg methyldopa anhydrous excipient: citric acid colloidal silicon dioxide disodium edetate dihydrate ethylcellulose guar gum magnesium stearate opadry yellow oy-8462 purified water sodium starch glycolate - hypertension (mild, moderate or severe).

United States - English - NLM (National Library of Medicine)

methyldopa tablet, film coated

rebel distributors corp - methyldopa (unii: 56lh93261y) (methyldopa - unii:56lh93261y) - hypertension. methyldopa is contraindicated in patients: - with active hepatic disease, such as acute hepatitis and active cirrhosis. - with liver disorders previously associated with methyldopa therapy (see warnings ). - with hypersensitivity to any component of this product. - on therapy with monoamine oxidase (mao) inhibitors.